Tata Chemicals (TATACHEM) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
27 Jul, 2026Executive summary
Segment reporting was restructured into Living Essentials, Industrial Essentials, and Farm Essentials to better align with business operations and investor feedback, focusing on non-cyclical, sustainability-led products.
Revenue for Q1FY27 rose to ₹4,255 crore, up 14% year-over-year, driven by higher sales volumes across segments.
EBITDA declined to ₹555 crore from ₹649 crore year-over-year, mainly due to lower export pricing from the US to South-East Asia.
PAT dropped to ₹60 crore from ₹316 crore year-over-year, impacted by lower realizations, reduced other income, and lower JV income.
Net debt decreased to ₹5,692 crore as of June 2026, reflecting asset monetization.
Financial highlights
Consolidated revenue: ₹4,255 crore (Q1FY27) vs. ₹3,719 crore (Q1FY26), a 14% increase.
EBITDA: ₹555 crore (Q1FY27) vs. ₹649 crore (Q1FY26); margin at 13%.
PAT: ₹60 crore (Q1FY27) vs. ₹316 crore (Q1FY26); margin at 1%.
Standalone EBITDA grew 35% and profit after tax from continuing operations increased 12% compared to Q1 last year.
Net debt reduced by ₹269 crore sequentially, aided by asset monetization.
Outlook and guidance
Global soda ash market faces near-term challenges from oversupply, especially from China, and elevated raw material and freight costs due to geopolitical tensions.
Domestic demand in India remains robust, with steady pricing expected; global pricing likely to stay subdued amid high inventories.
CapEx will focus on Living Essentials and de-commoditizing the portfolio, with major projects (salt and silica plants) expected to be operational by 2028.
Sustainability-driven demand from solar PV and EVs, plus potential synthetic capacity rationalization, supports a positive medium- to long-term outlook.
Sustainable EBITDA margin for India business estimated at 18%, with gross margin around 32%-33%.
Latest events from Tata Chemicals
- Net loss of ₹1,715 crore driven by US impairment, but leverage low and dividend maintained.TATACHEM
Q4 25/26 - Soda ash oversupply and weak prices drove losses, but India and expansions support future growth.TATACHEM
Q3 25/26 - India growth offset by weak global prices and UK closure; ₹1,500 crore NCD fund raise approved.TATACHEM
Q2 25/26 - Q1 FY26 saw higher profit and margins despite flat demand and global oversupply.TATACHEM
Q1 25/26 - Q2 FY25 revenue ₹3,999 crore, net profit ₹267 crore, expansions ramping up post-rains.TATACHEM
Q2 24/25 - Sequential revenue and EBITDA growth, but year-over-year declines amid European market headwinds.TATACHEM
Q1 24/25 - FY25 profit declined on lower realisation and UK impairments; dividend of ₹11.00 proposed.TATACHEM
Q4 24/25 - Revenue and profit fell on low prices and UK closure; net debt and risks increased.TATACHEM
Q3 24/25